FONAR Exhibits Stand-Up MRI at the Annual Meeting of the American Academy of Orthopedic Surgeons.
SAN FRANCISCO--(BUSINESS WIRE)--March 12, 2004
FONAR Corporation (NASDAQ-FONR), The MRI Specialist(TM), announced today that it is presently exhibiting its Stand-Up(TM) MRI at the 71st annual meeting of the American Academy of Orthopaedic Surgeons (AAOS). The annual AAOS meetings are among the world's largest meetings of orthopedic surgeons. This year's meeting is being held at the Moscone Convention Center in San Francisco, California from March 10-14, 2004. Total attendance is expected to reach approximately 30,000, including some 14,000 orthopedic surgeons and related healthcare professionals. FONAR's 30' x 50' exhibit is one of the larger of the more than 400 technical exhibits at the meeting.
Mr. Sol Ginzburg, vice president of sales at FONAR, said, "We exhibited at AAOS for the first time last year. Encouraged by results of that meeting, we're back again this year, and, once again, we are very pleased with the number of qualified sales leads we've collected."
"Since approximately 50% of MRI scans," continued Mr. Ginzburg, "are of the spine and joints, the orthopedic surgeon market is an extremely important one for the Stand-Up(TM) MRI. We've already sold several Stand-Up(TM) MRIs to surgeons and we feel that orthopedists and their patients will be an increasingly important focus for our product. You see, surgeons are beginning to realize that the ability to see anatomy in normal, upright, weight-bearing positions is often essential to achieving surgical successes on a consistent basis, and furthermore surgeons require seeing the 'whole picture of the pathology not just part of it as seen in a recumbent-only scanner."
The FONAR exhibit features regular multimedia presentations that include testimonials from Stand-Up(TM) MRI owners. Dr. Richard Marks, a board-certified orthopedic surgeon in Texas, said, "We had a patient who was experiencing pain in her lower spine. Although she had been scanned repeatedly, none of the scan results could explain why she was in pain - that is, until she had an MRI in the seated position in the FONAR Stand-Up(TM) MRI. The images, which incidentally were excellent in terms of image quality, showed a complete dislocation of the distal coccyx. This problem could only be identified because the patient was scanned upright."
Regarding surgeons and recumbent-only MRI scanners, board-certified radiologist Dr. Manuel Rose of Rose Radiology in Florida said, "Relying solely on an MRI exam of a supine patient is inadequate. Through no fault of their own, surgeons are at a serious disadvantage that could consequently result in failed surgeries."
FONAR has on display its full array of RF receiver coils, including its foot-ankle coil, a newly designed quadrature coil that will strengthen orthopedic practices by expanding weight-bearing MRI into the fields of pedal-orthotics and podiatry.
Neuro-radiologist J. Randy Jinkins, is making regular, well attended presentations of 'Upright, Weight-bearing Dynamic-Kinetic MRI (p/k MRI(TM)): The Pre- and Post- Operative Spine.' Dr. Jinkins, a professor of radiology at Downstate Medical Center in Brooklyn, New York, has three years of clinical experience with the Stand-Up(TM) MRI. Dr. Jinkins pointed out that the recumbent-only MRI can underestimate the maximum degree of pathology and miss its dynamic nature.
MRI Specialist, Stand-Up, Upright, Position, pMRI and The Proof is in the Picture are trademarks of FONAR Corporation
Be sure to visit FONAR's Web site for Company product and investor information: www.fonar.com
This release may include forward-looking statements from the company that may or may not materialize. Additional information on factors that could potentially affect the company's financial results may be found in the company's filings with the Securities and Exchange Commission.
|Printer friendly Cite/link Email Feedback|
|Date:||Mar 12, 2004|
|Previous Article:||Auto Club: Stratospheric Gas Prices Resist Downward Pressure.|
|Next Article:||A.P. Pharma Reports 2003 Fourth Quarter and Full Year Results; Reports Results of Open-Label APF112 Phase 2 study.|